Goodwin Procter LLP advised Vaccitech on the deal. Vaccitech announced the completion of its $168 million Series B, including the conversion of $43 million in convertible loan...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the initial purchasers on the deal. Everbridge, Inc. (“Everbridge”) issued an aggregate of $375 million principal amount of its 0% Convertible Senior Notes...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the initial purchasers on the deal. Cutera, Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with Stifel, Nicolaus & Company,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised ElevateBio on the deal. ElevateBio, a cell and gene therapy technology company focused on powering transformative cell and gene therapies, announced it...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Kosy Software Ltd on the deal. Kosy Software Ltd announced its seed financing round led by Picus Capital GmbH. Kosy is an...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the initial purchasers on the deal. MannKind Corporation (the “Company”) completed its previously announced private offering (the “Offering”) of $200.0 million aggregate...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Allen & Overy, Deloitte Tax & Legal, Goodwin Procter, Weil, Gotshal & Manges, advised on the matter. Allen & Overy advised Apax Partners with...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Monte Rosa Therapeutics on the deal. Monte Rosa Therapeutics, a biotechnology company focused on discovering and developing precision medicines that degrade disease-causing...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Charlesbank Capital Partners on the deal. Charlesbank Capital Partners, a middle-market private investment firm, announced that an affiliated fund has made a significant...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised JMI Equity on the deal. JMI Equity announced its strategic growth investment in Canto, a leading provider of digital asset management software. Canto...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Tessera Therapeutics on the deal. Tessera Therapeutics, an early-stage life sciences company founded by Flagship Pioneering, announced today that it has raised...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Valo Health on the deal. Valo Health announced the final closing of its Series B at $300 million, including a $110 million...
You must be a Standard 1 Year member to access this content.
